Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.5930
-0.0060 (-1.00%)
At close: Jun 27, 2025
6.46%
Market Cap 1.19B
Revenue (ttm) n/a
Net Income (ttm) -67.00M
Shares Out 2.01B
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,275,288
Average Volume 25,936,109
Open 0.6020
Previous Close 0.5990
Day's Range 0.5800 - 0.6090
52-Week Range 0.1528 - 0.8990
Beta 1.69
RSI 53.92
Earnings Date Aug 22, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.